These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14602213)

  • 41. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.
    Labinaz M; Sketch MH; Ellis SG; Abramowitz BM; Stebbins AL; Pieper KS; Holmes DR; Califf RM; Topol EJ
    Am Heart J; 2001 Mar; 141(3):469-77. PubMed ID: 11231447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method.
    Sutton AG; Campbell PG; Price DJ; Grech ED; Hall JA; Davies A; Stewart MJ; de Belder MA
    Heart; 2000 Aug; 84(2):149-56. PubMed ID: 10908249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
    Stewart JT; French JK; Théroux P; Ramanathan K; Solymoss BC; Johnson R; White HD
    J Am Coll Cardiol; 1998 Jun; 31(7):1499-505. PubMed ID: 9626826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative analysis of reperfusion time in primary angioplasty vs thrombolysis. Success vs time].
    Martínez Sánchez C; Martínez C; Lasses A; de la Peña E; Ramírez J; Luna J; González H; Chuquiure E; Juárez Herrera U; Martínez Ríos MA; González Romero S; Lupi E
    Arch Inst Cardiol Mex; 1999; 69(5):438-44. PubMed ID: 10640207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
    Zeymer U; Schröder R; Tebbe U; Molhoek GP; Wegscheider K; Neuhaus KL
    Eur Heart J; 2001 May; 22(9):769-75. PubMed ID: 11350109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
    Zijlstra F; Hoorntje JC; de Boer MJ; Reiffers S; Miedema K; Ottervanger JP; van 't Hof AW; Suryapranata H
    N Engl J Med; 1999 Nov; 341(19):1413-9. PubMed ID: 10547403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location.
    Henriques JP; Zijlstra F; van 't Hof AW; de Boer MJ; Dambrink JH; Gosselink AT; Hoorntje JC; Ottervanger JP; Suryapranata H
    Heart; 2006 Jan; 92(1):75-9. PubMed ID: 15831596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
    French JK; Andrews J; Manda SO; Stewart RA; McTigue JJ; White HD
    Am Heart J; 2002 Feb; 143(2):265-71. PubMed ID: 11835029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
    Shah A; Wagner GS; Granger CB; O'Connor CM; Green CL; Trollinger KM; Califf RM; Krucoff MW
    J Am Coll Cardiol; 2000 Mar; 35(3):666-72. PubMed ID: 10716469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
    Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
    Zijlstra F; de Boer MJ; Hoorntje JC; Reiffers S; Reiber JH; Suryapranata H
    N Engl J Med; 1993 Mar; 328(10):680-4. PubMed ID: 8433726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.